Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma
Clinical trial NCT04798781 · COMPLETED
Trial details
- NCT number
- NCT04798781
- Sponsor
- Andrew Hendifar, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-28
- Primary completion
- 2024-02-14
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.